Autoimmune thyroid disease in euthyroid subjects

OBJECTIVE: To determine the prevalence of thyroid autoantibodies and the associated factors in euthyroid subjects. METHODS: In this study, 300 euthyroid subjects chosen by stratified sampling from an inception cohort of 1335 individuals were included. None of the subjects was under treatment. Thyroi...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
spa
OAI Identifier:
oai:repository.urosario.edu.co:10336/18449
Acceso en línea:
https://doi.org/10.48713/10336_18449
http://repository.urosario.edu.co/handle/10336/18449
Palabra clave:
Euthyroidism
Anti-peroxidase autoantibodies
Anti-thyroglobulin autoantibodies
Autoimmune thyroid disease
Anatomía humana, citología, histología
Tiroides
Tiroglobulina
Autoanticuerpos
Rights
License
Atribución-NoComercial-SinDerivadas 2.5 Colombia
id EDOCUR2_87b37bdbcb2ee679715fe8a47d1a9e64
oai_identifier_str oai:repository.urosario.edu.co:10336/18449
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.spa.fl_str_mv Autoimmune thyroid disease in euthyroid subjects
title Autoimmune thyroid disease in euthyroid subjects
spellingShingle Autoimmune thyroid disease in euthyroid subjects
Euthyroidism
Anti-peroxidase autoantibodies
Anti-thyroglobulin autoantibodies
Autoimmune thyroid disease
Anatomía humana, citología, histología
Tiroides
Tiroglobulina
Autoanticuerpos
title_short Autoimmune thyroid disease in euthyroid subjects
title_full Autoimmune thyroid disease in euthyroid subjects
title_fullStr Autoimmune thyroid disease in euthyroid subjects
title_full_unstemmed Autoimmune thyroid disease in euthyroid subjects
title_sort Autoimmune thyroid disease in euthyroid subjects
dc.contributor.advisor.none.fl_str_mv Ramírez Santana, Heily Carolina
Molano González, Nicolás
dc.contributor.none.fl_str_mv Anaya, Juan-Manuel
Rojas, Manuel
Monsalve, Diana M.
Acosta-Ampudia, Yeny
Pacheco, Yovana
Rodríguez Jiménez, Mónica
dc.subject.spa.fl_str_mv Euthyroidism
Anti-peroxidase autoantibodies
Anti-thyroglobulin autoantibodies
Autoimmune thyroid disease
topic Euthyroidism
Anti-peroxidase autoantibodies
Anti-thyroglobulin autoantibodies
Autoimmune thyroid disease
Anatomía humana, citología, histología
Tiroides
Tiroglobulina
Autoanticuerpos
dc.subject.ddc.spa.fl_str_mv Anatomía humana, citología, histología
dc.subject.lemb.spa.fl_str_mv Tiroides
Tiroglobulina
Autoanticuerpos
description OBJECTIVE: To determine the prevalence of thyroid autoantibodies and the associated factors in euthyroid subjects. METHODS: In this study, 300 euthyroid subjects chosen by stratified sampling from an inception cohort of 1335 individuals were included. None of the subjects was under treatment. Thyroid function was evaluated by measuring serum levels of TSH (0.3-4.5 μIU / ml) and FT4 (5.2-12.7μg / dl). In addition, anti-peroxidase (TPOAbs), anti-thyroglobulin (TgAbs), and anti-TSH receptor (TrAbs) autoantibodies were evaluated together with other 23 autoantibodies and vitamin D levels. The analysis included sociodemographic, clinical, and environmental characteristics. Data were analyzed by chi-square (χ2), Kruskal-Wallis, Mann-Whitney and logistical regression tests. RESULTS: Thyroid autoimmunity was observed in 15.3% of the subjects (TPOAbs in 11.3% and TgAbs in 2%). In six individuals, both autoantibodies were positive. TrAbs were not detected in any individual. Familial thyroid disease (P = 0.021,  = 3.4 CI: 1.2 – 9.5), low libido (P = 0.013,  = 3.8 CI: 1.3 – 10.6), the presence of other ADs (P = 0.014,  = 10.8 CI: 1.6 – 72.9) were associated with thyroid autoantibodies. In addition, VitD insufficiency (P= 0.03), never smoke (P = 0.010,  = 6.9 CI: 1.6 – 30.4), drinking more than 4 cups of coffee (P = 0.036,  = 3.8 CI: 1.1 – 13.1), and higher number of years exposed to wood smoke (P = 0.04), were associated with thyroid autoantibodies. Similar the last analysis, the presence of TPOAbs was associated with familial thyroid disease (P = 0.003,  = 4.9 CI: 1.7 - 14.0), never smoke (P = 0.002,  = 5.7 CI: 1.4 - 21.0), drinking > 4 cups of coffee (P = 0.047,  = 3.6 CI: 1.1 - 13.1), low libido (P = 0.001,  = 5.7 CI: 2.0 - 16.3). In addition, the presence of SS-A / Ro52 (P = 0.009,  = 36.7 CI: 2.5 - 549.9), and Ku (P = 0.046,  = 10.2 CI: 1.1 - 100.7), also was related to these autoantibodies. Regarding TgAbs, the presence of African ancestry (P = 0.01,  = 10.5 CI: 1.7 – 63.2), SS-A / Ro52 (P = 0.03,  = 15.8 CI: 1.2 – 198.6), and CENP-B (P = 0.02,  = 31.2 CI: 1.8 – 565.9) was associated with TgAbs. CONCLUSIONS: Subclinical thyroid autoimmunity is not rare. Environmental, genetic, and immunological factors as well as ancestry are associated risk factors. These results will facilitate the implementation of screening strategies in order to provide timely diagnosis and treatment.
publishDate 2018
dc.date.accessioned.none.fl_str_mv 2018-09-06T16:39:12Z
dc.date.available.none.fl_str_mv 2018-09-06T16:39:12Z
dc.date.created.none.fl_str_mv 2018-09-04
dc.date.issued.none.fl_str_mv 2018
dc.type.eng.fl_str_mv bachelorThesis
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.spa.spa.fl_str_mv Trabajo de grado
dc.identifier.doi.none.fl_str_mv https://doi.org/10.48713/10336_18449
dc.identifier.uri.none.fl_str_mv http://repository.urosario.edu.co/handle/10336/18449
url https://doi.org/10.48713/10336_18449
http://repository.urosario.edu.co/handle/10336/18449
dc.language.iso.none.fl_str_mv spa
language spa
dc.rights.spa.fl_str_mv Atribución-NoComercial-SinDerivadas 2.5 Colombia
Atribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
dc.rights.uri.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
rights_invalid_str_mv Atribución-NoComercial-SinDerivadas 2.5 Colombia
Abierto (Texto Completo)
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad del Rosario
dc.publisher.department.spa.fl_str_mv Facultad de medicina
institution Universidad del Rosario
dc.source.bibliographicCitation.spa.fl_str_mv Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep;390(10101):1550–62.
Duntas LH. Thyroid Disease and Lipids. Thyroid. 2002 Apr;12(4):287–93.
Cappola AR, Ladenson PW. Hypothyroidism and Atherosclerosis. J Clin Endocrinol Metab. 2003 Jun;88(6):2438–44.
Parle J V, Maisonneuve P, Sheppard MC, Boyle P, Franklyn J a. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001 Sep;358(9285):861–5.
De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug;388(10047):906–18.
Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis. J Clin Endocrinol Metab. 2014 Mar;99(3):923–31.
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489–99.
Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States. Clin Immunol Immunopathol. 1997 Sep;84(3):223–43.
Pearce SHS, Leech NJ. Toward Precise Forecasting of Autoimmune Endocrinopathy. J Clin Endocrinol Metab. 2004 Feb;89(2):544–7.
Zöphel K, Saller B, Wunderlich G, Grüning T, Koch R, Wilde J, et al. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin Lab. 2003;49(11–12):591–600.
Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55–68.
Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K, et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol (Oxf). 1993 Mar;38(3):273–81.
Prentice LM, Phillips DI, Sarsero D, Beever K, McLachlan SM, Smith BR. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh). 1990 Nov;123(5):493–8.
Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol. 2000 Nov;143(5):639–47.
Pedersen IB, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf). 2003 Jan;58(1):36–42.
Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977 Dec;7(6):481–93.
Li Y, Teng D, Shan Z, Teng X, Guan H, Yu X, et al. Antithyroperoxidase and Antithyroglobulin Antibodies in a Five-Year Follow-Up Survey of Populations with Different Iodine Intakes. J Clin Endocrinol Metab. 2008 May;93(5):1751–7.
Sheu JJ, Kang JH, Lin HC, Lin HC. Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study. Stroke. 2010 May 1;41(5):961–6.
Ross DS, Neer RM, Chester Ridgway E, Daniels GH. Subclinical Hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-Thyroxine. Am J Med. 1987 Jun;82(6):1167–70.
Franco J-S, Amaya-Amaya J, Molano-González N, Caro-Moreno J, Rodríguez-Jiménez M, Acosta-Ampudia Y, et al. Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus. Clin Endocrinol (Oxf). 2015 Dec;83(6):943–50.
Anaya J-M. The autoimmune tautology. A summary of evidence. Jt Bone Spine. 2017 May;84(3):251–3.
Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet (London, England). 1992 Jun 20;339(8808):1506–8.
Anaya J-M. The autoimmune tautology. A summary of evidence. Jt Bone Spine. 2017 May;84(3):251–3.
Brent GA. Environmental exposures and autoimmune thyroid disease. Thyroid. 2010 Jul;20(7):755–61.
ngbar SH B LE, editor. The thyroid a fundamental and clinical text. Historical resume. In: 5th editio. Philadelphia: Lippincott; 1986. p. 3–6.
S. Werner. Historical resume. In: Ingbar SH. Braverman LE., editor. The thyroid a fundamental and clinical text. 5th editio. Philadelphia; Lippincott; 1986. p. 3–6.
Mario De Felice and Roberto Di Lauro. Anatomy and Development of the Thyroid. In: Jameson J. Larry, editor. Endocrinology Adult and pediatric. 7th editio. 2016. p. 1257–77.
Kopp P. Thyroid hormone synthesis: thyroid iodine metabolism. In: RD BLU, editor. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 9th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 52–76.
Mizukami Y, Michigishi T, Kawato M, Sato T, Nonomura A, Hashimoto T, et al. Chronic thyroiditis: thyroid function and histologic correlations in 601 cases. Hum Pathol. 1992 Sep;23(9):980–8.
Smith TJ, Hegedüs L. Graves’ Disease. Longo DL, editor. N Engl J Med. 2016 Oct 20;375(16):1552–65.
Prummel MF, Wiersinga WM. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab. 2005 Mar;19(1):1–15.
MARIOTTI S, CATUREGLI P, PICCOLO P, BARBESINO G, PINCHERA A. Antithyroid Peroxidase Autoantibodies in Thyroid Diseases*. J Clin Endocrinol Metab. 1990 Sep;71(3):661–9.
Fenouillet E, Fayet G, Hovsepian S, Bahraoui EM, Ronin C. Immunochemical evidence for a role of complex carbohydrate chains in thyroglobulin antigenicity. J Biol Chem. 1986 Nov 15;261(32):15153–8.
Parkes AB, McLachlan SM, Bird P, Rees Smith B. The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol. 1984 Jul;57(1):239–43.
Iddah MA, Macharia BN. Autoimmune Thyroid Disorders. ISRN Endocrinol. 2013;2013:1–9.
Ericsson U-B, Christensen SB, Thorell JI. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol. 1985 Nov;37(2):154–62.
Stathatos N, Daniels GH. Autoimmune thyroid disease. Curr Opin Rheumatol. 2012 Jan;24(1):70–5.
Effraimidis G, Wiersinga WM. MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014 May 17;170(6):R241–52.
Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015 Feb;14(2):174–80.
Tomer Y, Davies TF. Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function. Endocr Rev. 2003 Oct;24(5):694–717.
Brix TH, Hegedüs L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf). 2012 Apr;76(4):457–64.
Hansen PS, Brix TH, Iachine I, Kyvik KO, Hegedus L. The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. Eur J Endocrinol. 2006;154(1):29–38.
Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves’ disease. Hum Mol Genet. 2009;18(9):1704–13.
Ban Y, Tozaki T, Taniyama M, Skrabanek L, Nakano Y, Ban Y, et al. Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One. 2012;7(5):3–7.
Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future. J Autoimmun. 2007;28(2–3):85–98.
Siminovitch KA. PTPN22 and autoimmune disease. Nat Genet. 2004 Dec 1;36:1248.
Scalapino KJ, Daikh DI. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev. 2008 Jun;223:143–55.
Gough SCL, Simmonds MJ. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics. 2007 Nov;8(7):453–65.
Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, et al. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves’ disease. Thyroid. 2006 Apr;16(4):351–5.
Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013;9(5):277–87.
Pedersen IB, Knudsen N, Carle A, Vejbjerg P, Jorgensen T, Perrild H, et al. A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol (Oxf). 2011 Jul;75(1):120–6.
Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell’Unto E, Bartolomei MP, et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998 Oct 15;129(8):632–5.
Prummel MF, Wiersinga WM. Smoking and risk of Graves’ disease. JAMA. 1993 Jan 27;269(4):479–82.
Asvold BO, Bjoro T, Nilsen TIL, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007 Jul;167(13):1428–32.
Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012 Mar;76(3):315–25.
Kawashima A, Tanigawa K, Akama T, Yoshihara A, Ishii N, Suzuki K. Innate immune activation and thyroid autoimmunity. J Clin Endocrinol Metab. 2011 Dec;96(12):3661–71.
Roura-Mir C, Catalfamo M, Cheng T-Y, Marqusee E, Besra GS, Jaraquemada D, et al. CD1a and CD1c activate intrathyroidal T cells during Graves’ disease and Hashimoto’s thyroiditis. J Immunol. 2005 Mar;174(6):3773–80.
Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, et al. Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol. 2002 Jun;55(6):612–20.
Leskela S, Serrano A, de la Fuente H, Rodriguez-Munoz A, Ramos-Levi A, Sampedro-Nunez M, et al. Graves’ disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS One. 2015;10(4):e0123938.
Leskela S, Rodriguez-Munoz A, de la Fuente H, Figueroa-Vega N, Bonay P, Martin P, et al. Plasmacytoid dendritic cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2013 Jul;98(7):2822–33.
Mazziotti G, Sorvillo F, Naclerio C, Farzati A, Cioffi M, Perna R, et al. Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto’s thyroiditis. Eur J Endocrinol. 2003 Apr;148(4):383–8.
Eshaghkhani Y, Sanati MH, Nakhjavani M, Safari R, Khajavi A, Ataei M, et al. Disturbed Th1 and Th2 balance in patients with Graves’ disease. Minerva Endocrinol. 2016 Mar;41(1):28–36.
Ramos-Levi AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr. 2016 Oct;63(8):421–9.
Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen J, et al. Increased Frequency of Follicular Helper T Cells in Patients with Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 2012 Mar 1;97(3):943–50.
Glick AB, Wodzinski A, Fu P, Levine AD, Wald DN. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 2013 Jul;23(7):871–8.
Franco J-S, Molano-González N, Rodríguez-Jiménez M, Acosta-Ampudia Y, Mantilla RD, Amaya-Amaya J, et al. The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians. Crispin J, editor. PLoS One. 2014 Oct;9(10):e110242.
Vásquez-Awad, D., Cano-Gutiérrez, C. A., Gómez-Ortiz, A., González, M. Ángel, Guzmán-Moreno, R., Martínez-Reyes, J. I., Rosero-Olarte, O., Rueda-Beltz, C., & Acosta-Reyes JL. Vitamina D. Consenso colombiano de expertos. Rev Med. 2017;39(2):140–57.
Rojas M, Rodriguez Y, Pacheco Y, Zapata E, Monsalve DM, Mantilla RD, et al. Resilience in women with autoimmune rheumatic diseases. Joint Bone Spine. 2017 Dec;
Tunbridge WM, Brewis M, French JM, Appleton D, Bird T, Clark F, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):258–62.
Burek CL, Rose NR, Guire KE, Hoffman WH. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity. 1990;7(2–3):157–67.
McLeod DSA, Caturegli P, Cooper DS, Matos PG, Hutfless S. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA. 2014 Apr;311(15):1563–5.
Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet. 2003 Oct;73(4):736–47.
Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto’s thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet. 2001 Jun;10(13):1379–86.
Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab. 2002 Jan;87(1):404–7.
Vestergaard P. Smoking and thyroid disorders--a meta-analysis. Eur J Endocrinol. 2002 Feb;146(2):153–61.
Carle A, Bulow Pedersen I, Knudsen N, Perrild H, Ovesen L, Banke Rasmussen L, et al. Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clin Endocrinol (Oxf). 2012 Nov;77(5):764–72.
Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Surve. J Clin Endocrinol Metab. 2004 Dec;89(12):6077–86.
Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007 Feb;117(2):289–96.
Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci. 2011 Mar;68(6):931–49.
Karaconji IB. Facts about nicotine toxicity. Arh Hig Rada Toksikol. 2005 Dec;56(4):363–71.
Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun;362(24):2295–303.
Caturegli P, De Remigis A, Ferlito M, Landek-Salgado MA, Iwama S, Tzou S-C, et al. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology. 2012 Sep;153(9):4580–7.
Schmeltz LR, Blevins TC, Aronoff SL, Ozer K, Leffert JD, Goldberg MA, et al. Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto’s) thyroiditis: a randomized controlled clinical trial. J Clin Endocrinol Metab. 2014 Jan;99(1):E137-42.
Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983 Oct;2(9):425–9.
Pearce EN, Braverman LE. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):801–13.
Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2016 Jan 20;7:697.
Welsh P, Peters MJL, Sattar N. Vitamin D insufficiency. Vol. 364, The New England journal of medicine. United States; 2011. p. 1378–9; author reply 1380.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010 Aug;10(4):482–96.
Xu H, Soruri A, Gieseler RK, Peters JH. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol. 1993 Dec;38(6):535–40.
Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol. 2007 Jun;178(11):7190–8.
Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, et al. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol. 2009 Jul;157(1):48–59.
Lacka K, Maciejewski A. [Vitamin D in the etiopathogenesis of autoimmune thyroiditis]. Pol Merkur Lekarski. 2013 May;34(203):281–5.
Mazokopakis EE, Kotsiris DA. Hashimoto’s autoimmune thyroiditis and vitamin D deficiency. Current aspects. Hell J Nucl Med. 2014;17(1):37–40.
Chen W, Lin H, Wang M. Immune intervention effects on the induction of experimental autoimmune thyroiditis. J Huazhong Univ Sci Technol Med Sci = Hua zhong ke ji da xue xue bao Yi xue Ying wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2002;22(4):343–345,354.
Misharin A, Hewison M, Chen C-R, Lagishetty V, Aliesky HA, Mizutori Y, et al. Vitamin D deficiency modulates Graves’ hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology. 2009 Feb;150(2):1051–60.
Bae S-C, Lee YH. Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization. Clin Rheumatol. 2018 Sep;37(9):2415–21.
Clozel M, Branchaud CL, Tannenbaum GS, Dussault JH, Aranda J V. Effect of caffeine on thyroid and pituitary function in newborn rats. Pediatr Res. 1983 Jul;17(7):592–5.
Vaidya B, Kendall-Taylor P, Pearce SHS. The Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 2002 Dec 1;87(12):5385–97.
Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb;123(2):183.e1-9.
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/52ed5e85-6fdf-4bbd-a273-2d0a6a329fd9/download
https://repository.urosario.edu.co/bitstreams/d1797b7c-b9da-4876-be89-9291999fae84/download
https://repository.urosario.edu.co/bitstreams/0f3e6f0f-d52b-43ab-b198-dc6932b32f49/download
https://repository.urosario.edu.co/bitstreams/92598246-030c-4a66-9536-6680aef87cea/download
https://repository.urosario.edu.co/bitstreams/bb82d432-d050-4991-bfd8-10548daaa57d/download
bitstream.checksum.fl_str_mv f77f4224b8228084db7eac8337e6d6c7
fab9d9ed61d64f6ac005dee3306ae77e
9f5eb859bd5c30bc88515135ce7ba417
57e3babc02817f508b813cd71b4a837a
62a596b0a79cf9fc86d6940ac57fdf9e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390621552967680
spelling Anaya, Juan-ManuelRojas, ManuelMonsalve, Diana M.Acosta-Ampudia, YenyPacheco, YovanaRodríguez Jiménez, MónicaRamírez Santana, Heily Carolina52483526600Molano González, Nicolás80873475600Rodríguez Velandia, Yhojan AlexisEspecialista en Epidemiología (en Convenio con el CES)10229617356002018-09-06T16:39:12Z2018-09-06T16:39:12Z2018-09-042018OBJECTIVE: To determine the prevalence of thyroid autoantibodies and the associated factors in euthyroid subjects. METHODS: In this study, 300 euthyroid subjects chosen by stratified sampling from an inception cohort of 1335 individuals were included. None of the subjects was under treatment. Thyroid function was evaluated by measuring serum levels of TSH (0.3-4.5 μIU / ml) and FT4 (5.2-12.7μg / dl). In addition, anti-peroxidase (TPOAbs), anti-thyroglobulin (TgAbs), and anti-TSH receptor (TrAbs) autoantibodies were evaluated together with other 23 autoantibodies and vitamin D levels. The analysis included sociodemographic, clinical, and environmental characteristics. Data were analyzed by chi-square (χ2), Kruskal-Wallis, Mann-Whitney and logistical regression tests. RESULTS: Thyroid autoimmunity was observed in 15.3% of the subjects (TPOAbs in 11.3% and TgAbs in 2%). In six individuals, both autoantibodies were positive. TrAbs were not detected in any individual. Familial thyroid disease (P = 0.021,  = 3.4 CI: 1.2 – 9.5), low libido (P = 0.013,  = 3.8 CI: 1.3 – 10.6), the presence of other ADs (P = 0.014,  = 10.8 CI: 1.6 – 72.9) were associated with thyroid autoantibodies. In addition, VitD insufficiency (P= 0.03), never smoke (P = 0.010,  = 6.9 CI: 1.6 – 30.4), drinking more than 4 cups of coffee (P = 0.036,  = 3.8 CI: 1.1 – 13.1), and higher number of years exposed to wood smoke (P = 0.04), were associated with thyroid autoantibodies. Similar the last analysis, the presence of TPOAbs was associated with familial thyroid disease (P = 0.003,  = 4.9 CI: 1.7 - 14.0), never smoke (P = 0.002,  = 5.7 CI: 1.4 - 21.0), drinking > 4 cups of coffee (P = 0.047,  = 3.6 CI: 1.1 - 13.1), low libido (P = 0.001,  = 5.7 CI: 2.0 - 16.3). In addition, the presence of SS-A / Ro52 (P = 0.009,  = 36.7 CI: 2.5 - 549.9), and Ku (P = 0.046,  = 10.2 CI: 1.1 - 100.7), also was related to these autoantibodies. Regarding TgAbs, the presence of African ancestry (P = 0.01,  = 10.5 CI: 1.7 – 63.2), SS-A / Ro52 (P = 0.03,  = 15.8 CI: 1.2 – 198.6), and CENP-B (P = 0.02,  = 31.2 CI: 1.8 – 565.9) was associated with TgAbs. CONCLUSIONS: Subclinical thyroid autoimmunity is not rare. Environmental, genetic, and immunological factors as well as ancestry are associated risk factors. These results will facilitate the implementation of screening strategies in order to provide timely diagnosis and treatment.application/pdfhttps://doi.org/10.48713/10336_18449 http://repository.urosario.edu.co/handle/10336/18449spaUniversidad del RosarioFacultad de medicinaAtribución-NoComercial-SinDerivadas 2.5 ColombiaAtribución-NoComercial-SinDerivadas 2.5 ColombiaAbierto (Texto Completo)EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.http://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep;390(10101):1550–62.Duntas LH. Thyroid Disease and Lipids. Thyroid. 2002 Apr;12(4):287–93.Cappola AR, Ladenson PW. Hypothyroidism and Atherosclerosis. J Clin Endocrinol Metab. 2003 Jun;88(6):2438–44.Parle J V, Maisonneuve P, Sheppard MC, Boyle P, Franklyn J a. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001 Sep;358(9285):861–5.De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug;388(10047):906–18.Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis. J Clin Endocrinol Metab. 2014 Mar;99(3):923–31.Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489–99.Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States. Clin Immunol Immunopathol. 1997 Sep;84(3):223–43.Pearce SHS, Leech NJ. Toward Precise Forecasting of Autoimmune Endocrinopathy. J Clin Endocrinol Metab. 2004 Feb;89(2):544–7.Zöphel K, Saller B, Wunderlich G, Grüning T, Koch R, Wilde J, et al. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin Lab. 2003;49(11–12):591–600.Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55–68.Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K, et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol (Oxf). 1993 Mar;38(3):273–81.Prentice LM, Phillips DI, Sarsero D, Beever K, McLachlan SM, Smith BR. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh). 1990 Nov;123(5):493–8.Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol. 2000 Nov;143(5):639–47.Pedersen IB, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf). 2003 Jan;58(1):36–42.Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977 Dec;7(6):481–93.Li Y, Teng D, Shan Z, Teng X, Guan H, Yu X, et al. Antithyroperoxidase and Antithyroglobulin Antibodies in a Five-Year Follow-Up Survey of Populations with Different Iodine Intakes. J Clin Endocrinol Metab. 2008 May;93(5):1751–7.Sheu JJ, Kang JH, Lin HC, Lin HC. Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study. Stroke. 2010 May 1;41(5):961–6.Ross DS, Neer RM, Chester Ridgway E, Daniels GH. Subclinical Hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-Thyroxine. Am J Med. 1987 Jun;82(6):1167–70.Franco J-S, Amaya-Amaya J, Molano-González N, Caro-Moreno J, Rodríguez-Jiménez M, Acosta-Ampudia Y, et al. Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus. Clin Endocrinol (Oxf). 2015 Dec;83(6):943–50.Anaya J-M. The autoimmune tautology. A summary of evidence. Jt Bone Spine. 2017 May;84(3):251–3.Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet (London, England). 1992 Jun 20;339(8808):1506–8.Anaya J-M. The autoimmune tautology. A summary of evidence. Jt Bone Spine. 2017 May;84(3):251–3.Brent GA. Environmental exposures and autoimmune thyroid disease. Thyroid. 2010 Jul;20(7):755–61.ngbar SH B LE, editor. The thyroid a fundamental and clinical text. Historical resume. In: 5th editio. Philadelphia: Lippincott; 1986. p. 3–6.S. Werner. Historical resume. In: Ingbar SH. Braverman LE., editor. The thyroid a fundamental and clinical text. 5th editio. Philadelphia; Lippincott; 1986. p. 3–6.Mario De Felice and Roberto Di Lauro. Anatomy and Development of the Thyroid. In: Jameson J. Larry, editor. Endocrinology Adult and pediatric. 7th editio. 2016. p. 1257–77.Kopp P. Thyroid hormone synthesis: thyroid iodine metabolism. In: RD BLU, editor. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 9th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 52–76.Mizukami Y, Michigishi T, Kawato M, Sato T, Nonomura A, Hashimoto T, et al. Chronic thyroiditis: thyroid function and histologic correlations in 601 cases. Hum Pathol. 1992 Sep;23(9):980–8.Smith TJ, Hegedüs L. Graves’ Disease. Longo DL, editor. N Engl J Med. 2016 Oct 20;375(16):1552–65.Prummel MF, Wiersinga WM. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab. 2005 Mar;19(1):1–15.MARIOTTI S, CATUREGLI P, PICCOLO P, BARBESINO G, PINCHERA A. Antithyroid Peroxidase Autoantibodies in Thyroid Diseases*. J Clin Endocrinol Metab. 1990 Sep;71(3):661–9.Fenouillet E, Fayet G, Hovsepian S, Bahraoui EM, Ronin C. Immunochemical evidence for a role of complex carbohydrate chains in thyroglobulin antigenicity. J Biol Chem. 1986 Nov 15;261(32):15153–8.Parkes AB, McLachlan SM, Bird P, Rees Smith B. The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol. 1984 Jul;57(1):239–43.Iddah MA, Macharia BN. Autoimmune Thyroid Disorders. ISRN Endocrinol. 2013;2013:1–9.Ericsson U-B, Christensen SB, Thorell JI. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol. 1985 Nov;37(2):154–62.Stathatos N, Daniels GH. Autoimmune thyroid disease. Curr Opin Rheumatol. 2012 Jan;24(1):70–5.Effraimidis G, Wiersinga WM. MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014 May 17;170(6):R241–52.Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015 Feb;14(2):174–80.Tomer Y, Davies TF. Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function. Endocr Rev. 2003 Oct;24(5):694–717.Brix TH, Hegedüs L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf). 2012 Apr;76(4):457–64.Hansen PS, Brix TH, Iachine I, Kyvik KO, Hegedus L. The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. Eur J Endocrinol. 2006;154(1):29–38.Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves’ disease. Hum Mol Genet. 2009;18(9):1704–13.Ban Y, Tozaki T, Taniyama M, Skrabanek L, Nakano Y, Ban Y, et al. Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One. 2012;7(5):3–7.Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future. J Autoimmun. 2007;28(2–3):85–98.Siminovitch KA. PTPN22 and autoimmune disease. Nat Genet. 2004 Dec 1;36:1248.Scalapino KJ, Daikh DI. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev. 2008 Jun;223:143–55.Gough SCL, Simmonds MJ. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics. 2007 Nov;8(7):453–65.Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, et al. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves’ disease. Thyroid. 2006 Apr;16(4):351–5.Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013;9(5):277–87.Pedersen IB, Knudsen N, Carle A, Vejbjerg P, Jorgensen T, Perrild H, et al. A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol (Oxf). 2011 Jul;75(1):120–6.Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell’Unto E, Bartolomei MP, et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998 Oct 15;129(8):632–5.Prummel MF, Wiersinga WM. Smoking and risk of Graves’ disease. JAMA. 1993 Jan 27;269(4):479–82.Asvold BO, Bjoro T, Nilsen TIL, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007 Jul;167(13):1428–32.Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012 Mar;76(3):315–25.Kawashima A, Tanigawa K, Akama T, Yoshihara A, Ishii N, Suzuki K. Innate immune activation and thyroid autoimmunity. J Clin Endocrinol Metab. 2011 Dec;96(12):3661–71.Roura-Mir C, Catalfamo M, Cheng T-Y, Marqusee E, Besra GS, Jaraquemada D, et al. CD1a and CD1c activate intrathyroidal T cells during Graves’ disease and Hashimoto’s thyroiditis. J Immunol. 2005 Mar;174(6):3773–80.Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, et al. Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol. 2002 Jun;55(6):612–20.Leskela S, Serrano A, de la Fuente H, Rodriguez-Munoz A, Ramos-Levi A, Sampedro-Nunez M, et al. Graves’ disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS One. 2015;10(4):e0123938.Leskela S, Rodriguez-Munoz A, de la Fuente H, Figueroa-Vega N, Bonay P, Martin P, et al. Plasmacytoid dendritic cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2013 Jul;98(7):2822–33.Mazziotti G, Sorvillo F, Naclerio C, Farzati A, Cioffi M, Perna R, et al. Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto’s thyroiditis. Eur J Endocrinol. 2003 Apr;148(4):383–8.Eshaghkhani Y, Sanati MH, Nakhjavani M, Safari R, Khajavi A, Ataei M, et al. Disturbed Th1 and Th2 balance in patients with Graves’ disease. Minerva Endocrinol. 2016 Mar;41(1):28–36.Ramos-Levi AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr. 2016 Oct;63(8):421–9.Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen J, et al. Increased Frequency of Follicular Helper T Cells in Patients with Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 2012 Mar 1;97(3):943–50.Glick AB, Wodzinski A, Fu P, Levine AD, Wald DN. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 2013 Jul;23(7):871–8.Franco J-S, Molano-González N, Rodríguez-Jiménez M, Acosta-Ampudia Y, Mantilla RD, Amaya-Amaya J, et al. The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians. Crispin J, editor. PLoS One. 2014 Oct;9(10):e110242.Vásquez-Awad, D., Cano-Gutiérrez, C. A., Gómez-Ortiz, A., González, M. Ángel, Guzmán-Moreno, R., Martínez-Reyes, J. I., Rosero-Olarte, O., Rueda-Beltz, C., & Acosta-Reyes JL. Vitamina D. Consenso colombiano de expertos. Rev Med. 2017;39(2):140–57.Rojas M, Rodriguez Y, Pacheco Y, Zapata E, Monsalve DM, Mantilla RD, et al. Resilience in women with autoimmune rheumatic diseases. Joint Bone Spine. 2017 Dec;Tunbridge WM, Brewis M, French JM, Appleton D, Bird T, Clark F, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):258–62.Burek CL, Rose NR, Guire KE, Hoffman WH. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity. 1990;7(2–3):157–67.McLeod DSA, Caturegli P, Cooper DS, Matos PG, Hutfless S. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA. 2014 Apr;311(15):1563–5.Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet. 2003 Oct;73(4):736–47.Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto’s thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet. 2001 Jun;10(13):1379–86.Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab. 2002 Jan;87(1):404–7.Vestergaard P. Smoking and thyroid disorders--a meta-analysis. Eur J Endocrinol. 2002 Feb;146(2):153–61.Carle A, Bulow Pedersen I, Knudsen N, Perrild H, Ovesen L, Banke Rasmussen L, et al. Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clin Endocrinol (Oxf). 2012 Nov;77(5):764–72.Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Surve. J Clin Endocrinol Metab. 2004 Dec;89(12):6077–86.Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007 Feb;117(2):289–96.Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci. 2011 Mar;68(6):931–49.Karaconji IB. Facts about nicotine toxicity. Arh Hig Rada Toksikol. 2005 Dec;56(4):363–71.Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun;362(24):2295–303.Caturegli P, De Remigis A, Ferlito M, Landek-Salgado MA, Iwama S, Tzou S-C, et al. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology. 2012 Sep;153(9):4580–7.Schmeltz LR, Blevins TC, Aronoff SL, Ozer K, Leffert JD, Goldberg MA, et al. Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto’s) thyroiditis: a randomized controlled clinical trial. J Clin Endocrinol Metab. 2014 Jan;99(1):E137-42.Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983 Oct;2(9):425–9.Pearce EN, Braverman LE. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):801–13.Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2016 Jan 20;7:697.Welsh P, Peters MJL, Sattar N. Vitamin D insufficiency. Vol. 364, The New England journal of medicine. United States; 2011. p. 1378–9; author reply 1380.Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010 Aug;10(4):482–96.Xu H, Soruri A, Gieseler RK, Peters JH. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol. 1993 Dec;38(6):535–40.Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol. 2007 Jun;178(11):7190–8.Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, et al. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol. 2009 Jul;157(1):48–59.Lacka K, Maciejewski A. [Vitamin D in the etiopathogenesis of autoimmune thyroiditis]. Pol Merkur Lekarski. 2013 May;34(203):281–5.Mazokopakis EE, Kotsiris DA. Hashimoto’s autoimmune thyroiditis and vitamin D deficiency. Current aspects. Hell J Nucl Med. 2014;17(1):37–40.Chen W, Lin H, Wang M. Immune intervention effects on the induction of experimental autoimmune thyroiditis. J Huazhong Univ Sci Technol Med Sci = Hua zhong ke ji da xue xue bao Yi xue Ying wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2002;22(4):343–345,354.Misharin A, Hewison M, Chen C-R, Lagishetty V, Aliesky HA, Mizutori Y, et al. Vitamin D deficiency modulates Graves’ hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology. 2009 Feb;150(2):1051–60.Bae S-C, Lee YH. Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization. Clin Rheumatol. 2018 Sep;37(9):2415–21.Clozel M, Branchaud CL, Tannenbaum GS, Dussault JH, Aranda J V. Effect of caffeine on thyroid and pituitary function in newborn rats. Pediatr Res. 1983 Jul;17(7):592–5.Vaidya B, Kendall-Taylor P, Pearce SHS. The Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 2002 Dec 1;87(12):5385–97.Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb;123(2):183.e1-9.instname:Universidad del Rosarioreponame:Repositorio Institucional EdocUREuthyroidismAnti-peroxidase autoantibodiesAnti-thyroglobulin autoantibodiesAutoimmune thyroid diseaseAnatomía humana, citología, histología611600TiroidesTiroglobulinaAutoanticuerposAutoimmune thyroid disease in euthyroid subjectsbachelorThesisTrabajo de gradohttp://purl.org/coar/resource_type/c_7a1fORIGINALRodriguezVelandia-YhojanAlexis-2018.pdfRodriguezVelandia-YhojanAlexis-2018.pdfArtículo principalapplication/pdf2431306https://repository.urosario.edu.co/bitstreams/52ed5e85-6fdf-4bbd-a273-2d0a6a329fd9/downloadf77f4224b8228084db7eac8337e6d6c7MD54LICENSElicense.txtlicense.txttext/plain1475https://repository.urosario.edu.co/bitstreams/d1797b7c-b9da-4876-be89-9291999fae84/downloadfab9d9ed61d64f6ac005dee3306ae77eMD55CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8810https://repository.urosario.edu.co/bitstreams/0f3e6f0f-d52b-43ab-b198-dc6932b32f49/download9f5eb859bd5c30bc88515135ce7ba417MD56TEXTRodriguezVelandia-YhojanAlexis-2018.pdf.txtRodriguezVelandia-YhojanAlexis-2018.pdf.txtExtracted texttext/plain118769https://repository.urosario.edu.co/bitstreams/92598246-030c-4a66-9536-6680aef87cea/download57e3babc02817f508b813cd71b4a837aMD57THUMBNAILRodriguezVelandia-YhojanAlexis-2018.pdf.jpgRodriguezVelandia-YhojanAlexis-2018.pdf.jpgGenerated Thumbnailimage/jpeg2265https://repository.urosario.edu.co/bitstreams/bb82d432-d050-4991-bfd8-10548daaa57d/download62a596b0a79cf9fc86d6940ac57fdf9eMD5810336/18449oai:repository.urosario.edu.co:10336/184492019-09-19 07:37:54.609585http://creativecommons.org/licenses/by-nc-nd/2.5/co/Atribución-NoComercial-SinDerivadas 2.5 Colombiahttps://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.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

Publicaciones similares